Spyre Therapeutics, Inc. (SYRE)
(Delayed Data from NSDQ)
$28.70 USD
+1.48 (5.44%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $28.64 -0.06 (-0.21%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.81 | 0.00% |
Earnings Summary
For their last quarter, Spyre Therapeutics, Inc. (SYRE) reported earnings of -$0.86 per share, beating the Zacks Consensus Estimate of $-0.90 per share. This reflects a positive earnings surprise of 4.44%. Look out for SYRE's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.81 per share, reflecting a year-over-year increase of 76.38%.
Earnings History
Price & Consensus
Zacks News for SYRE
Here's Why Spyre Therapeutics (SYRE) Could be Great Choice for a Bottom Fisher
SYRE: What are Zacks experts saying now?
Zacks Private Portfolio Services